Bladder Cancer With FGFR3 Mutation or Fusion
1 clinical trials · Condition
◉ Watch Bladder Cancer With FGFR3 Mutation or Fusion
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies (NCT01004224) | Novartis Pharmaceuticals | 2009-12-11 |
Track Bladder Cancer With FGFR3 Mutation or Fusion automatically
Every clearance here is in the API, with alerts when new ones post.